Boston XO hexafocon ARecalls & reported problems
Bausch & Lomb Incorporated · Rigid Gas Permeable Contact Lens · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 0
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
No MAUDE adverse event reports in our data reference this device identifier directly.
2 FDA recall records name this device's identifier.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Recalls naming this device
- Jul 3, 2018Terminated
Vials labeled for the prescriptions contained incorrect lenses
Z-2982-2018 · Root cause: Process control · FDA record ↗
- Jul 3, 2018Terminated
Vials labeled for the prescriptions contained incorrect lenses
Z-2981-2018 · Root cause: Process control · FDA record ↗
Other Lens, Contact (Other Material) - Daily devices
- Boston XO2 hexafocon BBausch & Lomb Incorporated · Lens, Contact (Other Material) - Daily3 recalls1 report
- Optimum Extra roflufocon DContamac Holdings Limited · Lens, Contact (Other Material) - Daily3 recalls1 report
- Optimum Extreme roflufocon EContamac Holdings Limited · Lens, Contact (Other Material) - Daily3 recalls0 reports
- Optimum Infinite Tisilfocon AContamac Holdings Limited · Lens, Contact (Other Material) - Daily2 recalls0 reports
- HEXA100 hexafocon AContamac Holdings Limited · Lens, Contact (Other Material) - Daily1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page